Open in interactive viewer → charts, metric popovers & call review

Stellus Swaps a Deal Story for a History Lesson at 0.7x Book

A 20% dividend yield, six stubborn nonaccruals, and a vanished Ridgepost narrative — defended with 22 years of track record
SCM · Earnings Call · 2026-11-10

The theme that disappeared

For most of 2026, the defining story at Stellus Capital was not credit — it was corporate. The external adviser was joining Ridgepost Capital, and the company's keyword set was dominated by it: private credit sat at the very top of the Q1 2026 list, alongside joining Ridgepost Capital, RCP Advisors, and sponsor relationships as the promised deal-flow multiplier. On the August call, Rob Ladd was still framing it as a pipeline story: the RCP combination was “still early there -- early days there, but we think this will take a few quarters or so” — Robert Ladd, Chief Executive Officer · 2026-08-11. On the third-quarter call there is not a single mention of Ridgepost, RCP Advisors, or the sponsor-funnel thesis. The entire topic is gone from both the prepared remarks and the Q&A. What replaced it is not a new growth narrative but a recital of the past: Life to date jumped to the top of the keyword set, flanked by credit cycle, equity gain, equity co investment, and leverage level. When a company substitutes its own history for its forward story, that substitution is the story.

First, we are one of the longest-tenured active private credit managers with a history of investing that is 22 years across 400 companies and $10 billion of deployment.

Robert Ladd, CEO or Senior Executive · 2026-11-10

What the tape is saying that the script is answering

The stock is down 16.6% over the last 90 trading days and 22.8% from its August 13 peak of $8.91. The valuation has de-rated hard: price to book of 0.66x, down 38% year over year and 38% below the 1.1x peak reached in 2025Q1. The market is not debating the coupon; it is debating whether the marks are right. Management's rebuttal is a wall of longevity statistics — 230 portfolio companies since the 2012 IPO, $1.9 billion of repayments, “we have generated a life-to-date return on equity for our investors of 9.2%” — Robert Ladd, CEO or Senior Executive · 2026-11-10, and $356 million of dividends, or $19.08 per share. The most interesting part of that argument is the equity co-invest book: roughly 5% of the portfolio at cost, which management sizes at ~$90 million at fair value in August. Because it carries no borrowing base, Ladd calls it free capital — “One of the repayments that we may receive over the next 2 to 3 months would include a nice equity gain.” — Robert Ladd, CEO or Senior Executive · 2026-11-10 That is the recycling thesis: harvest equity, re-lever it in the SBIC at 2:1. But the quarter's headline number undercuts the tone. “net asset value decreased by $0.40 per share or 3%, driven by 2 primary factors” — W. Huskinson, CFO or Finance Executive · 2026-11-10 — $0.48 of realized and unrealized losses, partly offset by $0.08 of buyback accretion. Ladd's framing of that move as “a 3% movement. So it's -- I know it may seem large, but that's a small movement” — Robert Ladd, CEO or Senior Executive · 2026-11-10 is technically fair and rhetorically telling: NAV has now oscillated around $12 for a year while the share price has broken down.

The number that refuses to improve

Credit quality is where the calm wears thinnest. Six portfolio companies sit on nonaccrual — “the level of nonaccruals remains higher than historical averages” — W. Huskinson, CFO or Finance Executive · 2026-11-10 — representing 9.6% of cost and 5.4% of fair value, with 22% of the portfolio rated 3 or below. This is a multi-quarter drumbeat, not a surprise: in August, an analyst opened with “the nonaccruals have been elevated for some time” — Christopher Nolan, Analyst · 2026-08-11, and in May Ladd insisted they were “all company specific” — Robert T. Ladd, Chief Executive Officer · 2026-05-12 rather than vintage or macro driven. The resolution timeline, however, has quietly slipped. In May the expectation was a pullback “toward the end of the year” — Robert T. Ladd, Chief Executive Officer · 2026-05-12; today there is no date, only a promise that experience says they revert to more moderate levels. And one position already burned: a sponsor-marketed company drew poor bids, “turned out there were not attractive offers that came in and ultimately sold to another party at a discount” — Robert Ladd, CEO or Senior Executive · 2026-11-10, forcing a $4.5 million write-down in Q3 and a realized loss in Q4. That is the honest tell — recoveries are lumpy, and the equity book is where the upside optionality lives, not the debt marks.

The dividend reversal, and a buyback of unusual restraint

Six months ago Ladd told shareholders plainly that “our expectation is that the dividend will be coming down” — Robert T. Ladd, Chief Executive Officer · 2026-05-12. The current call reverses that: with core NII of $0.26 and a favorable rising interest rates environment — management cites the recent increase in SOFR — Stellus now expects to earn its $0.25 quarterly distribution going forward. The market's read is stark, as Chris Nolan put it:

given where the stock price is right now and your current dividend is over 20%, which is unbelievably high... I would imagine being really aggressive on the share repurchases makes a lot of sense just from preserving capital down the road.

Christopher Nolan, Analyst · 2026-11-10
Yet against a $20 million authorization, only $6.6 million (767,880 shares) has been used in 2026. The current dividend is defended verbally while the buyback stays cautious: “we just want to balance maintaining our equity base and our leverage level” — Robert Ladd, CEO or Senior Executive · 2026-11-10. That is the real intellectual tension of the call. If book value is right, repurchasing at 0.66x is the highest-return asset the company can buy — far better than a 5.5% SOFR spread. If book value is soft, buying it is value destruction. Management behaves as if it suspects the latter, even while telling investors the former. Leverage is the constraint they cite: liabilities at 62.6% of assets, down modestly over four years, with regulatory leverage near 1:1 against a 2:1 GAAP target. There is capacity; there is not conviction.

SBIC III is now the growth engine

The forward case has been re-founded on the third SBIC license. The vehicle holds $23 million of investments, with three more deals (~$25 million) expected by year-end, and the SBA recently lifted the family-of-funds debenture cap from $350 million to $475 million. Management sizes the opportunity at up to $100 million of incremental portfolio — roughly 10% of today's $966 million across 119 companies — financed with long-dated, low-cost, government-guaranteed paper rather than a borrowing base associated with the credit facility. That is a credible, if slow, earnings lever and a much better story than reciting 2012. But it is also the second consecutive quarter in which the growth answer is 'SBIC' rather than 'the sponsor relationships we just acquired.' For a BDC priced at 8.1x trailing net income with a 75% net margin on $22 million of quarterly revenue, the market is not paying for history. It is waiting to see the nonaccrual count fall, the equity gains actually cash out, and whether a 0.7x book gets bought — by insiders or by the company. Watch Q4's realized loss and the first 2027 equity realization; they are the only two data points that resolve the argument.